https://ntp.niehs.nih.gov/go/11589

TDMS Study 97013-92 Pathology Tables

NTP                                        STATISTICAL ANALYSIS OF PRIMARY TUMORS                              REPORT: PEIRPT08     
LAB: Battelle Columbus                          WATER DISINFECTION MODEL (SODIUM BROMATE)                      DATE: 12/08/03       
EXPERIMENT: 97013 TEST: 92                                                                                     TIME: 14:31:08       
TEST TYPE:  26-39 WEEKS                         CAGES FROM 0000 TO LAST CAGE                                   PAGE:       1        
CONT: N01-ES-65406                              ROUTE: SKIN APPLICATION                                        NTP C#: 97013B       
PATHOLOGIST: TOFT, JOHN                                                                                        CAS: 7789-38-0       
------------------------------------------------------------------------------------------------------------------------------------
                                                            FINAL#1 MICE                                                            
               REASONS FOR REMOVAL:    25019 Moribund Sacrifice                                                                     
                                       25020 Natural Death                                                                          
                                       25021 Terminal Sacrifice                                                                     
               REMOVAL DATE RANGE:     ALL                                                                                          
               TREATMENT GROUPS:       INCLUDE ALL                                                                                  
NTP                                        STATISTICAL ANALYSIS OF PRIMARY TUMORS                              REPORT: PEIRPT08     
LAB: Battelle Columbus                          WATER DISINFECTION MODEL (SODIUM BROMATE)                      DATE: 12/08/03       
EXPERIMENT: 97013 TEST: 92                                                                                     TIME: 14:31:08       
TEST TYPE:  26-39 WEEKS                         CAGES FROM 0000 TO LAST CAGE                                                        
CONT: N01-ES-65406                              ROUTE: SKIN APPLICATION                                        NTP C#: 97013B       
PATHOLOGIST: TOFT, JOHN                                                                                        CAS: 7789-38-0       
Mice(TG.AC HETEROZYGOUS TRANSGENIC)                                                                                                 
-----------------------------                                                                                                       
FOR ALL DOSES THE TUMOR RATES IN THE FOLLOWING TISSUES/ORGANS ARE                                                                   
BASED ON NUMBER OF TISSUES EXAMINED.  IN OTHER TISSUES/ORGANS RATES                                                                 
ARE BASED ON THE NUMBER OF ANIMALS NECROPSIED.                                                                                      
                                                 ---------------                                                                    
                                                 Lung                                                                               
                                                 Ovary                                                                              
                                                 Salivary Glands                                                                    
NTP                                        STATISTICAL ANALYSIS OF PRIMARY TUMORS                              REPORT: PEIRPT08     
LAB: Battelle Columbus                          WATER DISINFECTION MODEL (SODIUM BROMATE)                      DATE: 12/08/03       
EXPERIMENT: 97013 TEST: 92                                                                                     TIME: 14:31:08       
TEST TYPE:  26-39 WEEKS                         CAGES FROM 0000 TO LAST CAGE                                                        
CONT: N01-ES-65406                              ROUTE: SKIN APPLICATION                                        NTP C#: 97013B       
PATHOLOGIST: TOFT, JOHN                                                                                        CAS: 7789-38-0       
SUMMARY OF STATISTICALLY SIGNIFICANT (P<=.05) RESULTS                                                                               
IN THE ANALYSIS OF        WATER DISINFECTION MODEL (SODIUM BR                                                                       
===============================================================                                                                     
Female Mice                                                                                                                         
------------                                                                                                                        
Organ                                  Morphology                                                                                   
-----                                  ----------                                                                                   
Stomach, Forestomach                   Squamous Cell Papilloma                                                                      
===============================================================                                                                     
       Date:  12/08/03                           EXPERIMENT: 97013 TEST: 92                                            Page 1       
Statistical Analysis of Primary Tumors in Mice(TG.AC HETEROZYGOUS TRANSGENIC)        -         WATER DISINFECTION MODEL (SODIUM BR  
                                         Terminal Sacrifice at 39 weeks                                                             
|=================================================================================================================================| 
|                   |                                                        |                                                    | 
|                   |                              Males                     |                       Females                      | 
|Dose               |     0 MG/KG      64 MG/KG     128          256         |0 MG/KG      64 MG/KG     128          256          | 
|                   |                               MG/KG        MG/KG       |                          MG/KG        MG/KG        | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Lung                                                                                                                             | 
|     Alveolar/Bronchiolar Adenoma                                                                                                | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                        |                                                    | 
|-----------        |                                                        |                                                    | 
|OVERALL (a)        |     1/10 (10%)   2/10 (20%)   1/10 (10%)   1/10 (10%)  |0/9 (0%)     0/10 (0%)    0/10 (0%)    1/10 (10%)   | 
|POLY-3 RATE (b)    |     1/8.63       2/8.92       1/9.32       1/8.55      |0/8.29       0/7.32       0/8.64       1/9.36       | 
|POLY-3 PERCENT (g) |     11.6%        22.4%        10.7%        11.7%       |0.0%         0.0%         0.0%         10.7%        | 
|TERMINAL (d)       |     1/8 (13%)    2/8 (25%)    1/8 (13%)    1/8 (13%)   |0/7 (0%)     0/7 (0%)     0/8 (0%)     1/8 (13%)    | 
|FIRST INCIDENCE    |     272 (T)      272 (T)      272 (T)      272 (T)     |---          ---          ---          272 (T)      | 
|-------------------|                                                        |                                                    | 
|STATISTICAL TESTS  |                                                        |                                                    | 
|-------------------|                                                        |                                                    | 
|LIFE TABLE         |     P=0.532N     P=0.500      P=0.768      P=0.768     |P=0.216      (e)          (e)          P=0.527      | 
|POLY 3             |     P=0.530N     P=0.512      P=0.745N     P=0.761     |P=0.222      (e)          (e)          P=0.524      | 
|POLY 1.5           |     P=0.534N     P=0.508      P=0.748N     P=0.757     |P=0.219      (e)          (e)          P=0.523      | 
|POLY 6             |     P=0.528N     P=0.515      P=0.746N     P=0.763N    |P=0.222      (e)          (e)          P=0.526      | 
|LOGISTIC REGRESSION|     P=0.532N     P=0.500      P=0.768      P=0.768     |(e)          (e)          (e)          P=0.527      | 
|COCH-ARM / FISHERS |     P=0.532N     P=0.500      P=0.763N     P=0.763N    |P=0.203      (e)          (e)          P=0.526      | 
|ORDER RESTRICTED   |     P=0.579N     (e)          (e)          (e)         |P=0.143      (e)          (e)          (e)          | 
|=================================================================================================================================| 
|                   |                                                        |                                                    | 
|                   |                              Males                     |                       Females                      | 
|Dose               |     0 MG/KG      64 MG/KG     128          256         |0 MG/KG      64 MG/KG     128          256          | 
|                   |                               MG/KG        MG/KG       |                          MG/KG        MG/KG        | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Salivary Glands                                                                                                                  | 
|     Carcinoma                                                                                                                   | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                        |                                                    | 
|-----------        |                                                        |                                                    | 
|OVERALL (a)        |     2/2 (100%)   0/0 (0%)     0/0 (0%)     0/0 (0%)    |0/1 (0%)     1/1 (100%)   1/1 (100%)   0/0 (0%)     | 
|POLY-3 RATE (b)    |     2/2.00       0/0.00       0/0.00       0/0.00      |0/1.00       1/1.00       1/1.00       0/0.00       | 
|POLY-3 PERCENT (g) |     100.0%       0.0%         0.0%         0.0%        |0.0%         100.0%       100.0%       0.0%         | 
|TERMINAL (d)       |     1/1 (100%)   0/0 (0%)     0/0 (0%)     0/0 (0%)    |0/1 (0%)     0/0 (0%)     1/1 (100%)   0/0 (0%)     | 
|FIRST INCIDENCE    |     134          ---          ---          ---         |---          144          272 (T)      ---          | 
|-------------------|                                                        |                                                    | 
|STATISTICAL TESTS  |                                                        |                                                    | 
|-------------------|                                                        |                                                    | 
|LIFE TABLE         |     (e)          (e)          (e)          (e)         |P=0.675      P=0.527      P=0.500      (e)          | 
|POLY 3             |     (e)          (e)          (e)          (e)         |(e)          P=1.000N     P=1.000N     (e)          | 
|POLY 1.5           |     (e)          (e)          (e)          (e)         |(e)          P=1.000N     P=1.000N     (e)          | 
|POLY 6             |     (e)          (e)          (e)          (e)         |(e)          P=1.000N     P=1.000N     (e)          | 
|LOGISTIC REGRESSION|     (e)          (e)          (e)          (e)         |(e)          (e)          P=0.250      (e)          | 
|COCH-ARM / FISHERS |     (e)          (e)          (e)          (e)         |P=0.500      P=0.500      P=0.500      (e)          | 
|ORDER RESTRICTED   |     (e)          (e)          (e)          (e)         |(e)          (e)          (e)          (e)          | 
|=================================================================================================================================| 
       Date:  12/08/03                           EXPERIMENT: 97013 TEST: 92                                            Page 2       
Statistical Analysis of Primary Tumors in Mice(TG.AC HETEROZYGOUS TRANSGENIC)       -         WATER DISINFECTION MODEL (SODIUM BR   
                                         Terminal Sacrifice at 39 weeks                                                             
|=================================================================================================================================| 
|                   |                                                        |                                                    | 
|                   |                              Males                     |                       Females                      | 
|Dose               |     0 MG/KG      64 MG/KG     128          256         |0 MG/KG      64 MG/KG     128          256          | 
|                   |                               MG/KG        MG/KG       |                          MG/KG        MG/KG        | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Skin                                                                                                                             | 
|     Basal or Sq. Cell Carcinoma, Carcinoma, Basosq. Tumor                                                                       | 
|     (M or B), Basal Cell Adenoma, Adenoma, Papilloma, Sq Papilloma, Keratoacanthoma, Trichoepitheliom                           | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            | 
|-----------        |                                                        |                                                    | 
|OVERALL (a)        |     7/10 (70%)   9/10 (90%)   6/10 (60%)   6/10 (60%)  |6/9 (67%)    5/10 (50%)   5/10 (50%)   5/10 (50%)   | 
|POLY-3 RATE (b)    |     7/8.63       9/9.14       6/9.79       6/9.02      |6/8.51       5/7.32       5/8.64       5/9.52       | 
|POLY-3 PERCENT (g) |     81.1%        98.5%        61.3%        66.6%       |70.5%        68.3%        57.9%        52.6%        | 
|TERMINAL (d)       |     7/8 (88%)    8/8 (100%)   5/8 (63%)    5/8 (63%)   |5/7 (71%)    5/7 (71%)    5/8 (63%)    4/8 (50%)    | 
|FIRST INCIDENCE    |     272 (T)      251          221          221         |251          272 (T)      272 (T)      257          | 
|-------------------|                                                        |                                                    | 
|STATISTICAL TESTS  |                                                        |                                                    | 
|-------------------|                                                        |                                                    | 
|LIFE TABLE         |     P=0.236N     P=0.253      P=0.478N     P=0.489N    |P=0.284N     P=0.513N     P=0.377N     P=0.373N     | 
|POLY 3             |     P=0.157N     P=0.309      P=0.338N     P=0.440N    |P=0.265N     P=0.670N     P=0.483N     P=0.385N     | 
|POLY 1.5           |     P=0.202N     P=0.282      P=0.391N     P=0.491N    |P=0.285N     P=0.610N     P=0.460N     P=0.390N     | 
|POLY 6             |     P=0.120N     P=0.377      P=0.302N     P=0.383N    |P=0.256N     P=0.682N     P=0.495N     P=0.379N     | 
|LOGISTIC REGRESSION|     P=0.222N     P=0.354      P=0.385N     P=0.505N    |P=0.248N     P=0.648N     P=0.439N     P=0.364N     | 
|COCH-ARM / FISHERS |     P=0.242N     P=0.291      P=0.500N     P=0.500N    |P=0.356N     P=0.395N     P=0.395N     P=0.395N     | 
|ORDER RESTRICTED   |     P=0.143N     (e)          (e)          (e)         |P=0.339N     (e)          (e)          (e)          | 
|=================================================================================================================================| 
|                   |                                                        |                                                    | 
|                   |                              Males                     |                       Females                      | 
|Dose               |     0 MG/KG      64 MG/KG     128          256         |0 MG/KG      64 MG/KG     128          256          | 
|                   |                               MG/KG        MG/KG       |                          MG/KG        MG/KG        | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Skin                                                                                                                             | 
|     Squamous Cell Papilloma                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            | 
|-----------        |                                                        |                                                    | 
|OVERALL (a)        |     7/10 (70%)   9/10 (90%)   6/10 (60%)   6/10 (60%)  |6/9 (67%)    5/10 (50%)   5/10 (50%)   5/10 (50%)   | 
|POLY-3 RATE (b)    |     7/8.63       9/9.14       6/9.79       6/9.02      |6/8.51       5/7.32       5/8.64       5/9.52       | 
|POLY-3 PERCENT (g) |     81.1%        98.5%        61.3%        66.6%       |70.5%        68.3%        57.9%        52.6%        | 
|TERMINAL (d)       |     7/8 (88%)    8/8 (100%)   5/8 (63%)    5/8 (63%)   |5/7 (71%)    5/7 (71%)    5/8 (63%)    4/8 (50%)    | 
|FIRST INCIDENCE    |     272 (T)      251          221          221         |251          272 (T)      272 (T)      257          | 
|-------------------|                                                        |                                                    | 
|STATISTICAL TESTS  |                                                        |                                                    | 
|-------------------|                                                        |                                                    | 
|LIFE TABLE         |     P=0.236N     P=0.253      P=0.478N     P=0.489N    |P=0.284N     P=0.513N     P=0.377N     P=0.373N     | 
|POLY 3             |     P=0.157N     P=0.309      P=0.338N     P=0.440N    |P=0.265N     P=0.670N     P=0.483N     P=0.385N     | 
|POLY 1.5           |     P=0.202N     P=0.282      P=0.391N     P=0.491N    |P=0.285N     P=0.610N     P=0.460N     P=0.390N     | 
|POLY 6             |     P=0.120N     P=0.377      P=0.302N     P=0.383N    |P=0.256N     P=0.682N     P=0.495N     P=0.379N     | 
|LOGISTIC REGRESSION|     P=0.222N     P=0.354      P=0.385N     P=0.505N    |P=0.248N     P=0.648N     P=0.439N     P=0.364N     | 
|COCH-ARM / FISHERS |     P=0.242N     P=0.291      P=0.500N     P=0.500N    |P=0.356N     P=0.395N     P=0.395N     P=0.395N     | 
|ORDER RESTRICTED   |     P=0.143N     (e)          (e)          (e)         |P=0.339N     (e)          (e)          (e)          | 
|=================================================================================================================================| 
       Date:  12/08/03                           EXPERIMENT: 97013 TEST: 92                                            Page 3       
Statistical Analysis of Primary Tumors in Mice(TG.AC HETEROZYGOUS TRANSGENIC)       -         WATER DISINFECTION MODEL (SODIUM BR   
                                         Terminal Sacrifice at 39 weeks                                                             
|=================================================================================================================================| 
|                   |                                                        |                                                    | 
|                   |                              Males                     |                       Females                      | 
|Dose               |     0 MG/KG      64 MG/KG     128          256         |0 MG/KG      64 MG/KG     128          256          | 
|                   |                               MG/KG        MG/KG       |                          MG/KG        MG/KG        | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Skin                                                                                                                             | 
|     Squamous Cell Papilloma, Papilloma, Squamous Cell                                                                           | 
|     Carcinoma or Keratoacanthoma                                                                                                | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            | 
|-----------        |                                                        |                                                    | 
|OVERALL (a)        |     7/10 (70%)   9/10 (90%)   6/10 (60%)   6/10 (60%)  |6/9 (67%)    5/10 (50%)   5/10 (50%)   5/10 (50%)   | 
|POLY-3 RATE (b)    |     7/8.63       9/9.14       6/9.79       6/9.02      |6/8.51       5/7.32       5/8.64       5/9.52       | 
|POLY-3 PERCENT (g) |     81.1%        98.5%        61.3%        66.6%       |70.5%        68.3%        57.9%        52.6%        | 
|TERMINAL (d)       |     7/8 (88%)    8/8 (100%)   5/8 (63%)    5/8 (63%)   |5/7 (71%)    5/7 (71%)    5/8 (63%)    4/8 (50%)    | 
|FIRST INCIDENCE    |     272 (T)      251          221          221         |251          272 (T)      272 (T)      257          | 
|-------------------|                                                        |                                                    | 
|STATISTICAL TESTS  |                                                        |                                                    | 
|-------------------|                                                        |                                                    | 
|LIFE TABLE         |     P=0.236N     P=0.253      P=0.478N     P=0.489N    |P=0.284N     P=0.513N     P=0.377N     P=0.373N     | 
|POLY 3             |     P=0.157N     P=0.309      P=0.338N     P=0.440N    |P=0.265N     P=0.670N     P=0.483N     P=0.385N     | 
|POLY 1.5           |     P=0.202N     P=0.282      P=0.391N     P=0.491N    |P=0.285N     P=0.610N     P=0.460N     P=0.390N     | 
|POLY 6             |     P=0.120N     P=0.377      P=0.302N     P=0.383N    |P=0.256N     P=0.682N     P=0.495N     P=0.379N     | 
|LOGISTIC REGRESSION|     P=0.222N     P=0.354      P=0.385N     P=0.505N    |P=0.248N     P=0.648N     P=0.439N     P=0.364N     | 
|COCH-ARM / FISHERS |     P=0.242N     P=0.291      P=0.500N     P=0.500N    |P=0.356N     P=0.395N     P=0.395N     P=0.395N     | 
|ORDER RESTRICTED   |     P=0.143N     (e)          (e)          (e)         |P=0.339N     (e)          (e)          (e)          | 
|=================================================================================================================================| 
|                   |                                                        |                                                    | 
|                   |                              Males                     |                       Females                      | 
|Dose               |     0 MG/KG      64 MG/KG     128          256         |0 MG/KG      64 MG/KG     128          256          | 
|                   |                               MG/KG        MG/KG       |                          MG/KG        MG/KG        | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Skin                                                                                                                             | 
|     Squamous Cell Papilloma, Papilloma, or Keratoacanthoma                                                                      | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            | 
|-----------        |                                                        |                                                    | 
|OVERALL (a)        |     7/10 (70%)   9/10 (90%)   6/10 (60%)   6/10 (60%)  |6/9 (67%)    5/10 (50%)   5/10 (50%)   5/10 (50%)   | 
|POLY-3 RATE (b)    |     7/8.63       9/9.14       6/9.79       6/9.02      |6/8.51       5/7.32       5/8.64       5/9.52       | 
|POLY-3 PERCENT (g) |     81.1%        98.5%        61.3%        66.6%       |70.5%        68.3%        57.9%        52.6%        | 
|TERMINAL (d)       |     7/8 (88%)    8/8 (100%)   5/8 (63%)    5/8 (63%)   |5/7 (71%)    5/7 (71%)    5/8 (63%)    4/8 (50%)    | 
|FIRST INCIDENCE    |     272 (T)      251          221          221         |251          272 (T)      272 (T)      257          | 
|-------------------|                                                        |                                                    | 
|STATISTICAL TESTS  |                                                        |                                                    | 
|-------------------|                                                        |                                                    | 
|LIFE TABLE         |     P=0.236N     P=0.253      P=0.478N     P=0.489N    |P=0.284N     P=0.513N     P=0.377N     P=0.373N     | 
|POLY 3             |     P=0.157N     P=0.309      P=0.338N     P=0.440N    |P=0.265N     P=0.670N     P=0.483N     P=0.385N     | 
|POLY 1.5           |     P=0.202N     P=0.282      P=0.391N     P=0.491N    |P=0.285N     P=0.610N     P=0.460N     P=0.390N     | 
|POLY 6             |     P=0.120N     P=0.377      P=0.302N     P=0.383N    |P=0.256N     P=0.682N     P=0.495N     P=0.379N     | 
|LOGISTIC REGRESSION|     P=0.222N     P=0.354      P=0.385N     P=0.505N    |P=0.248N     P=0.648N     P=0.439N     P=0.364N     | 
|COCH-ARM / FISHERS |     P=0.242N     P=0.291      P=0.500N     P=0.500N    |P=0.356N     P=0.395N     P=0.395N     P=0.395N     | 
|ORDER RESTRICTED   |     P=0.143N     (e)          (e)          (e)         |P=0.339N     (e)          (e)          (e)          | 
|=================================================================================================================================| 
       Date:  12/08/03                           EXPERIMENT: 97013 TEST: 92                                            Page 4       
Statistical Analysis of Primary Tumors in Mice(TG.AC HETEROZYGOUS TRANSGENIC)       -         WATER DISINFECTION MODEL (SODIUM BR   
                                         Terminal Sacrifice at 39 weeks                                                             
|=================================================================================================================================| 
|                   |                                                        |                                                    | 
|                   |                              Males                     |                       Females                      | 
|Dose               |     0 MG/KG      64 MG/KG     128          256         |0 MG/KG      64 MG/KG     128          256          | 
|                   |                               MG/KG        MG/KG       |                          MG/KG        MG/KG        | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Stomach, Forestomach                                                                                                             | 
|     Squamous Cell Papilloma                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            | 
|-----------        |                                                        |                                                    | 
|OVERALL (a)        |     3/10 (30%)   3/10 (30%)   2/10 (20%)   4/10 (40%)  |2/9 (22%)    2/10 (20%)   7/10 (70%)   4/10 (40%)   | 
|POLY-3 RATE (b)    |     3/8.63       3/8.92       2/9.32       4/9.02      |2/8.29       2/7.32       7/9.10       4/9.52       | 
|POLY-3 PERCENT (g) |     34.7%        33.6%        21.5%        44.4%       |24.1%        27.3%        76.9%        42.0%        | 
|TERMINAL (d)       |     3/8 (38%)    3/8 (38%)    2/8 (25%)    3/8 (38%)   |2/7 (29%)    2/7 (29%)    6/8 (75%)    3/8 (38%)    | 
|FIRST INCIDENCE    |     272 (T)      272 (T)      272 (T)      221         |272 (T)      272 (T)      221          257          | 
|-------------------|                                                        |                                                    | 
|STATISTICAL TESTS  |                                                        |                                                    | 
|-------------------|                                                        |                                                    | 
|LIFE TABLE         |     P=0.413      P=0.691      P=0.500N     P=0.510     |P=0.230      P=0.716      P=0.063      P=0.400      | 
|POLY 3             |     P=0.432      P=0.668N     P=0.461N     P=0.528     |P=0.242      P=0.660      P=0.027 *    P=0.387      | 
|POLY 1.5           |     P=0.414      P=0.673N     P=0.470N     P=0.505     |P=0.221      P=0.675      P=0.027 *    P=0.380      | 
|POLY 6             |     P=0.452      P=0.664N     P=0.463N     P=0.554     |P=0.261      P=0.667      P=0.033 *    P=0.400      | 
|LOGISTIC REGRESSION|     P=0.399      P=0.691      P=0.500N     P=0.491     |P=0.228      P=0.716      P=0.035 *    P=0.381      | 
|COCH-ARM / FISHERS |     P=0.408      P=0.686N     P=0.500N     P=0.500     |P=0.181      P=0.667N     P=0.051      P=0.370      | 
|ORDER RESTRICTED   |     P=0.421      (e)          (e)          (e)         |P=0.087      (e)          (e)          (e)          | 
|=================================================================================================================================| 
|                   |                                                        |                                                    | 
|                   |                              Males                     |                       Females                      | 
|Dose               |     0 MG/KG      64 MG/KG     128          256         |0 MG/KG      64 MG/KG     128          256          | 
|                   |                               MG/KG        MG/KG       |                          MG/KG        MG/KG        | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Tooth                                                                                                                            | 
|     Odontogenic Tumor                                                                                                           | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            | 
|-----------        |                                                        |                                                    | 
|OVERALL (a)        |     2/10 (20%)   3/10 (30%)   3/10 (30%)   2/10 (20%)  |2/9 (22%)    3/10 (30%)   3/10 (30%)   3/10 (30%)   | 
|POLY-3 RATE (b)    |     2/8.63       3/8.92       3/9.32       2/9.02      |2/9.00       3/7.32       3/9.54       3/9.52       | 
|POLY-3 PERCENT (g) |     23.2%        33.6%        32.2%        22.2%       |22.2%        41.0%        31.5%        31.5%        | 
|TERMINAL (d)       |     2/8 (25%)    3/8 (38%)    3/8 (38%)    1/8 (13%)   |0/7 (0%)     3/7 (43%)    2/8 (25%)    2/8 (25%)    | 
|FIRST INCIDENCE    |     272 (T)      272 (T)      272 (T)      221         |217          272 (T)      127          257          | 
|-------------------|                                                        |                                                    | 
|STATISTICAL TESTS  |                                                        |                                                    | 
|-------------------|                                                        |                                                    | 
|LIFE TABLE         |     P=0.543N     P=0.500      P=0.500      P=0.690N    |P=0.522      P=0.464      P=0.534      P=0.567      | 
|POLY 3             |     P=0.524N     P=0.517      P=0.539      P=0.689N    |P=0.484      P=0.396      P=0.529      P=0.528      | 
|POLY 1.5           |     P=0.543N     P=0.511      P=0.530      P=0.703N    |P=0.491      P=0.434      P=0.539      P=0.538      | 
|POLY 6             |     P=0.503N     P=0.521      P=0.537      P=0.674N    |P=0.468      P=0.377      P=0.516      P=0.514      | 
|LOGISTIC REGRESSION|     P=0.557N     P=0.500      P=0.500      P=0.707     |P=0.472      P=0.480      P=0.686      P=0.528      | 
|COCH-ARM / FISHERS |     P=0.549N     P=0.500      P=0.500      P=0.709N    |P=0.475      P=0.556      P=0.556      P=0.556      | 
|ORDER RESTRICTED   |     P=0.576N     (e)          (e)          (e)         |P=0.463      (e)          (e)          (e)          | 
|=================================================================================================================================| 
       Date:  12/08/03                           EXPERIMENT: 97013 TEST: 92                                            Page 5       
Statistical Analysis of Primary Tumors in Mice(TG.AC HETEROZYGOUS TRANSGENIC)       -         WATER DISINFECTION MODEL (SODIUM BR   
                                         Terminal Sacrifice at 39 weeks                                                             
|=================================================================================================================================| 
|                   |                                                        |                                                    | 
|                   |                              Males                     |                       Females                      | 
|Dose               |     0 MG/KG      64 MG/KG     128          256         |0 MG/KG      64 MG/KG     128          256          | 
|                   |                               MG/KG        MG/KG       |                          MG/KG        MG/KG        | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|All Organs                                                                                                                       | 
|     Benign Tumors                                                                                                               | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            | 
|-----------        |                                                        |                                                    | 
|OVERALL (a)        |     7/10 (70%)   9/10 (90%)   6/10 (60%)   6/10 (60%)  |6/9 (67%)    5/10 (50%)   8/10 (80%)   8/10 (80%)   | 
|POLY-3 RATE (b)    |     7/8.63       9/9.14       6/9.79       6/9.02      |6/8.51       5/7.32       8/9.10       8/9.52       | 
|POLY-3 PERCENT (g) |     81.1%        98.5%        61.3%        66.6%       |70.5%        68.3%        87.9%        84.1%        | 
|TERMINAL (d)       |     7/8 (88%)    8/8 (100%)   5/8 (63%)    5/8 (63%)   |5/7 (71%)    5/7 (71%)    7/8 (88%)    7/8 (88%)    | 
|FIRST INCIDENCE    |     272 (T)      251          221          221         |251          272 (T)      221          257          | 
|-------------------|                                                        |                                                    | 
|STATISTICAL TESTS  |                                                        |                                                    | 
|-------------------|                                                        |                                                    | 
|LIFE TABLE         |     P=0.236N     P=0.253      P=0.478N     P=0.489N    |P=0.284      P=0.513N     P=0.474      P=0.497      | 
|POLY 3             |     P=0.157N     P=0.309      P=0.338N     P=0.440N    |P=0.281      P=0.670N     P=0.377      P=0.450      | 
|POLY 1.5           |     P=0.202N     P=0.282      P=0.391N     P=0.491N    |P=0.264      P=0.610N     P=0.381      P=0.449      | 
|POLY 6             |     P=0.120N     P=0.377      P=0.302N     P=0.383N    |P=0.286      P=0.682N     P=0.406      P=0.453      | 
|LOGISTIC REGRESSION|     P=0.222N     P=0.354      P=0.385N     P=0.505N    |P=0.290      P=0.648N     P=0.320      P=0.484      | 
|COCH-ARM / FISHERS |     P=0.242N     P=0.291      P=0.500N     P=0.500N    |P=0.202      P=0.395N     P=0.444      P=0.444      | 
|ORDER RESTRICTED   |     P=0.143N     (e)          (e)          (e)         |P=0.301      (e)          (e)          (e)          | 
|=================================================================================================================================| 
|                   |                                                        |                                                    | 
|                   |                              Males                     |                       Females                      | 
|Dose               |     0 MG/KG      64 MG/KG     128          256         |0 MG/KG      64 MG/KG     128          256          | 
|                   |                               MG/KG        MG/KG       |                          MG/KG        MG/KG        | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|All Organs                                                                                                                       | 
|     Malignant Tumors                                                                                                            | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            | 
|-----------        |                                                        |                                                    | 
|OVERALL (a)        |     3/10 (30%)   2/10 (20%)   1/10 (10%)   1/10 (10%)  |2/9 (22%)    1/10 (10%)   1/10 (10%)   1/10 (10%)   | 
|POLY-3 RATE (b)    |     3/9.52       2/10.00      1/9.54       1/9.54      |2/8.51       1/8.17       1/8.64       1/9.36       | 
|POLY-3 PERCENT (g) |     31.5%        20.0%        10.5%        10.5%       |23.5%        12.2%        11.6%        10.7%        | 
|TERMINAL (d)       |     2/8 (25%)    0/8 (0%)     0/8 (0%)     0/8 (0%)    |1/7 (14%)    0/7 (0%)     1/8 (13%)    1/8 (13%)    | 
|FIRST INCIDENCE    |     134          140          251          69          |251          144          272 (T)      272 (T)      | 
|-------------------|                                                        |                                                    | 
|STATISTICAL TESTS  |                                                        |                                                    | 
|-------------------|                                                        |                                                    | 
|LIFE TABLE         |     P=0.205N     P=0.480N     P=0.295N     P=0.315N    |P=0.362N     P=0.515N     P=0.469N     P=0.455N     | 
|POLY 3             |     P=0.190N     P=0.475N     P=0.289N     P=0.289N    |P=0.365N     P=0.515N     P=0.494N     P=0.465N     | 
|POLY 1.5           |     P=0.189N     P=0.486N     P=0.290N     P=0.290N    |P=0.365N     P=0.509N     P=0.486N     P=0.463N     | 
|POLY 6             |     P=0.193N     P=0.462N     P=0.288N     P=0.288N    |P=0.369N     P=0.510N     P=0.498N     P=0.469N     | 
|LOGISTIC REGRESSION|     P=0.115N     P=0.570N     P=0.411N     P=0.213N    |P=0.393N     P=0.355N     P=0.480N     P=0.459N     | 
|COCH-ARM / FISHERS |     P=0.180N     P=0.500N     P=0.291N     P=0.291N    |P=0.376N     P=0.458N     P=0.458N     P=0.458N     | 
|ORDER RESTRICTED   |     P=0.193N     (e)          (e)          (e)         |P=0.360N     (e)          (e)          (e)          | 
|=================================================================================================================================| 
       Date:  12/08/03                           EXPERIMENT: 97013 TEST: 92                                            Page 6       
Statistical Analysis of Primary Tumors in Mice(TG.AC HETEROZYGOUS TRANSGENIC)       -         WATER DISINFECTION MODEL (SODIUM BR   
                                         Terminal Sacrifice at 39 weeks                                                             
|=================================================================================================================================| 
|                   |                                                        |                                                    | 
|                   |                              Males                     |                       Females                      | 
|Dose               |     0 MG/KG      64 MG/KG     128          256         |0 MG/KG      64 MG/KG     128          256          | 
|                   |                               MG/KG        MG/KG       |                          MG/KG        MG/KG        | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|All Organs                                                                                                                       | 
|     Malignant and Benign Tumors                                                                                                 | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |     #            #            #            #           |#            #            #            #            | 
|-----------        |                                                        |                                                    | 
|OVERALL (a)        |     9/10 (90%)   10/10 (100%) 7/10 (70%)   7/10 (70%)  |7/9 (78%)    7/10 (70%)   10/10 (100%) 9/10 (90%)   | 
|POLY-3 RATE (b)    |     9/9.52       10/10.00     7/10.00      7/10.00     |7/9.00       7/8.17       10/10.00     9/9.52       | 
|POLY-3 PERCENT (g) |     94.6%        100.0%       70.0%        70.0%       |77.8%        85.7%        100.0%       94.6%        | 
|TERMINAL (d)       |     8/8 (100%)   8/8 (100%)   5/8 (63%)    5/8 (63%)   |5/7 (71%)    6/7 (86%)    8/8 (100%)   8/8 (100%)   | 
|FIRST INCIDENCE    |     134          140          221          69          |217          144          127          257          | 
|-------------------|                                                        |                                                    | 
|STATISTICAL TESTS  |                                                        |                                                    | 
|-------------------|                                                        |                                                    | 
|LIFE TABLE         |     P=0.173N     P=0.526      P=0.310N     P=0.335N    |P=0.375      P=0.635      P=0.336      P=0.519      | 
|POLY 3             |     P=0.050N     P=0.815      P=0.197N     P=0.197N    |P=0.167      P=0.578      P=0.201      P=0.350      | 
|POLY 1.5           |     P=0.064N     P=0.646      P=0.236N     P=0.236N    |P=0.201      P=0.640      P=0.201      P=0.400      | 
|POLY 6             |     P=0.036N*    P=0.996      P=0.154N     P=0.154N    |P=0.119      P=0.548      P=0.201      P=0.287      | 
|LOGISTIC REGRESSION|     P=0.085N     P=0.515      P=0.283N     P=0.282N    |P=0.264      P=0.647      (e)          P=0.479      | 
|COCH-ARM / FISHERS |     P=0.091N     P=0.500      P=0.291N     P=0.291N    |P=0.202      P=0.556N     P=0.211      P=0.458      | 
|ORDER RESTRICTED   |     P=0.068N     (e)          (e)          (e)         |P=0.108      (e)          (e)          (e)          | 
|=================================================================================================================================| 
(a)  Number of tumor-bearing animals /  number of animals examined at site.                                                         
(b)  Number of tumor-bearing animals / Poly-3 number                                                                                
(d)  Observed incidence at terminal kill.                                                                                           
(f)  Beneath the control incidence are the P-values associated with the trend                                                       
test.  Beneath the dosed group incidence are the P-values corresponding to                                                          
pairwise comparisons between the controls and that dosed group.  The life                                                           
table analysis regards tumors in animals dying prior to  terminal kill as                                                           
 being (directly or indirectly) the cause of death.                                                                                 
Logistic regression is an alternative                                                                                               
 method for analyzing the incidence of non-fatal tumors. The Cochran-Armitage                                                       
and Fishers exact tests compare directly the overall incidence rates                                                                
For all tests a negative trend is indicated by N                                                                                    
(e)  Value of Statistic cannot be computed.                                                                                         
(g)  Poly-3 adjusted lifetime tumor incidence.                                                                                      
(I)  Interim sacrifice                                                                                                              
(T)  Terminal sacrifice                                                                                                             
#   Tumor rates based on number of animals necropsied.                                                                              
*   To the right of any statistical result, indicates significance at (P<=0.05).                                                    
**  To the right of any statistical result, indicates significance at (P<=0.01).